Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
COVID Hub
›
COVID-19 Therapies
COVID-19 Therapies
15/12/2022
Interim Clinical Commissioning Policy - Baricitinib for patients hospitalised due to C-19 - 28 Nov.pdf
15/12/2022
Covid-19 Therapeutic Alert - Baricitinib for patients hospitalised due to C-19 - 28 November.pdf
05/12/2022
Covid-19 Therapeutic Alert - Remdesivir for patients hospitalised due to C-19 - 28 November.pdf
05/12/2022
Interim Clinical Commissioning Policy - Remdesivir for patients hospitalised due to C-19 - 28 Nov.pdf
05/12/2022
Clinical Guide - Therapies for patients hospitalised due to COVID-19 - 28 November.pdf
05/12/2022
Covid-19 Therapeutic Alert - IL-6 inhibitors (tocilizumab or sarilumab) for adults patients hospitalised due to C-19 - 29 November.pdf
05/12/2022
Interim Clinical Commissioning Policy - IL-6 inhibitors for patients hospitalised due to COVID-19 - 28 November.pdf
06/07/2022
Public Health Link - Palivizumab Passive Immunisation Programme against RSV - July 2022.pdf
01/06/2022
Public Health Link - Antivirals or Neutralising Antibodies (Non-hospitalised).pdf
01/06/2022
Clinical Guide - Patients with symptomatic hospital-onset COVID-19.pdf
01/06/2022
Clinical Guide - Symptomatic non-hospitalised patients with COVID-19.pdf
01/06/2022
Interim Clinical Commissioning Policy - Antivirals or neutralising monoclonal antibodies (non-hospitalised).pdf
01/06/2022
Interim Clinical Commissioning Policy - Antivirals or neutralising monoclonal antibodies (hospital-onset) - 30 May.pdf
01/06/2022
Public Health Link - Antivirals or Neutralising Monoclonal Antibodies (Hospital onset) - 1 June.pdf
05/05/2022
Clinical Guide - Patients hospitalised due to COVID-19.pdf
05/05/2022
Interim Clinical Commissioning Policy - Baricitinib in hospitalised patients - 5 May.pdf
05/05/2022
Public Health Link - Baricitinib for hospitalised patients - 5 May.pdf
01/03/2022
Interim Clinical Commissioning Policy - nMAbs in non-hospitalised patients - 24 Feb.pdf
01/03/2022
Public Health Link - nMAbs in non-hospitalised patients - 28 Feb.pdf
25/02/2022
Remdesivir for patients hospitalised due to COVID-19 feb 22
1
2
3
4
Follow AWTTC: